Results 81 to 90 of about 43,328 (269)

Surgical limb‐sparing in veterinary medicine: A review of existing techniques in dogs

open access: yesVeterinary Surgery, EarlyView.
Abstract Surgical limb‐sparing in veterinary medicine can be defined as an intervention aimed at preserving limb function when a bone abnormality is present, namely neoplasia or a non‐repairable fracture, and the affected segment of that bone needs to be removed and, most often, replaced.
Johnny Altwal, Bernard Séguin
wiley   +1 more source

Multiple or metastatic clear cell chondrosarcoma: a case report [PDF]

open access: yes, 2014
We report multiple synchronous clear-cell chondrosarcomas in a 43-year-old patient. The patient had a lesion in the right proximal humerus and in the left femoral condyle. Bone scintigraphy revealed increased uptake in both foci.
Alberto Righi   +4 more
core   +2 more sources

A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi‐Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De‐Differentiated Chondrosarcoma

open access: yesCancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background We present the case of 72–year‐old male with metastatic de‐differentiated chondrosarcoma (“DDCS”). DDCS is a rare soft tissue cancer that carries a dismal prognosis in the metastatic stage, and is resistant to both traditional chemotherapy and radiotherapy. There is a distinct lack of proven systemic therapies. Case This case report
Matthew Youssef, Peter Grimison
wiley   +1 more source

c-Maf Transcription Factor Regulates ADAMTS-12 Expression in Human Chondrogenic Cells. [PDF]

open access: yes, 2013
ObjectiveADAMTS (a disintegrin and metalloproteinase with thrombospondin type-1 motif) zinc metalloproteinases are important during the synthesis and breakdown of cartilage extracellular matrix.
Amanatullah, Derek F   +4 more
core   +2 more sources

Juxtacortical chondrosarcoma [PDF]

open access: yesThe Journal of Bone and Joint Surgery. British volume, 1977
The features are described of seven cases of "juxtacortical" chondrosarcoma, the term introduced by Jaffe for a rare but distinct entity and now accepted in the World Health Organisation classification as preferable to the term "periosteal" chondrosarcoma.
openaire   +2 more sources

Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification

open access: yesThe Journal of Pathology, Volume 268, Issue 2, Page 227-242, February 2026.
Abstract Carcinosarcomas (CSs) are aggressive biphasic tumors characterized by epithelial and mesenchymal components, whose histogenesis and differentiation dynamics remain poorly understood. We present single‐nucleus RNA sequencing (snRNA‐seq) analysis of six CSs (five endometrial and one ovarian) and two normal endometrial samples, profiling over 96 ...
Silvia González‐Martínez   +9 more
wiley   +1 more source

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma

open access: yesCancer Management and Research, 2021
Changbao Chen,1 Hua Zhou,2 Xiaolin Zhang,1 Zhongjun Liu,2 Xinlong Ma1 1Department of Spinal Surgery, Tianjin Hospital, Tianjin, 300211, People’s Republic of China; 2Department of Orthopaedic Surgery, Peking University Third Hospital, Beijing ...
Chen C, Zhou H, Zhang X, Liu Z, Ma X
doaj  

Chondrosarcoma of the Proximal Phalanx of the Fourth Digit: A Rare Location

open access: yesCase Reports in Oncology, 2012
Introduction: Cartilaginous tumors involving the small bones of the hands and feet are usually benign such as enchondroma, chondromyxoid fibroma and chondroblastoma.
Thivi Vasilakaki   +8 more
doaj   +1 more source

Children and Adolescents With Localised Non‐Rhabdomyosarcoma Soft Tissue Sarcoma: Results of the CWS‐96 and CWS‐2002P Prospective Trials With Reclassification of the Trial Data Incorporating the Recent Soft Tissue Sarcoma Registry

open access: yesPediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background Here we report the results of the first comprehensive European trials for all soft tissue sarcoma entities, which aimed to develop a new risk stratification system, limit radiotherapy and chemotherapy for low‐/standard‐risk patients, and evaluate different chemotherapy regimens for high‐risk patients.
Amadeus T. Heinz   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy